TrkB transmembrane domain: bridging structural understanding with therapeutic strategy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

TrkB transmembrane domain: bridging structural understanding with therapeutic strategy

Published:2024-05 Issue:5 Volume:49 Page:445-456
ISSN:0968-0004
Container-title:Trends in Biochemical Sciences
language:en
Short-container-title:Trends in Biochemical Sciences

Author:

Enkavi Giray^ORCID,Girych Mykhailo^ORCID,Moliner Rafael^ORCID,Vattulainen Ilpo^ORCID,Castrén Eero^ORCID

Funder

Jane and Aatos Erkko Fundation

Sigrid Jusélius Foundation

University of Helsinki Helsinki Institute of Life Sciences

Human Frontier Science Program

Academy of Finland

Lundbeck Foundation

Publisher

Elsevier BV

Reference100 articles.

1. Neurotrophins: from enthusiastic expectations through sobering experiences to rational therapeutic approaches;Thoenen;Nat. Neurosci.,2002

2. Clinical tests of neurotrophic factors for human neurodegenerative diseases, part 1: where have we been and what have we learned?;Bartus;Neurobiol. Dis.,2017

3. Are TrkB receptor agonists the right tool to fulfill the promises for a therapeutic value of the brain-derived neurotrophic factor;Zagrebelsky;Neural Regen. Res.,2024

4. Neurotrophins and their receptors: a convergence point for many signalling pathways;Chao;Nat. Rev. Neurosci.,2003

5. Neurotrophin receptors TrkA and TrkC cause neuronal death whereas TrkB does not;Nikoletopoulou;Nature,2010

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Psychoactive substances for the treatment of neuropsychiatric disorders;Asian Journal of Psychiatry;2024-11

2. Neuron and astrocyte specific 5mC and 5hmC signatures of BDNF’s receptor, TrkB;Frontiers in Molecular Neuroscience;2024-08-29

3. A Combined Computational and Experimental Approach to Studying Tropomyosin Kinase Receptor B Binders for Potential Treatment of Neurodegenerative Diseases;Molecules;2024-08-23

4. Pyrazolo[1,5-a]pyrimidine as a Prominent Framework for Tropomyosin Receptor Kinase (Trk) Inhibitors—Synthetic Strategies and SAR Insights;Molecules;2024-07-29

5. BDNF-TrkB Signaling in Mitochondria: Implications for Neurodegenerative Diseases;Molecular Neurobiology;2024-07-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3